{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:44:59Z","timestamp":1785167099937,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejmg.2022.104473","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T11:54:57Z","timestamp":1646049297000},"page":"104473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Could distal variants in ALG13 lead to atypical clinical presentation?"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8724-6721","authenticated-orcid":false,"given":"Andrea","family":"Accogli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-7736","authenticated-orcid":false,"given":"Silvia","family":"Radenkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasantha","family":"Ranatunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-3086","authenticated-orcid":false,"given":"Anna N.","family":"Ligezka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Trakadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.ejmg.2022.104473_bib1","doi-asserted-by":"crossref","first-page":"34500","DOI":"10.1074\/jbc.M506358200","article-title":"Biosynthesis of lipid-linked oligosaccharides in Saccharomyces cerevisiae: alg13p and Alg14p form a complex required for the formation of GlcNAc(2)-PP-dolichol","volume":"280","author":"Bickel","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.ejmg.2022.104473_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation","volume":"6","author":"Chang","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.ejmg.2022.104473_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/epi.16761","article-title":"The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy","volume":"62","author":"Datta","year":"2021","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejmg.2022.104473_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jimd.12348","article-title":"An international classification of inherited metabolic disorders (ICIMD)","volume":"44","author":"Ferreira","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmg.2022.104473_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-neuro-071714-034019","article-title":"Neurological aspects of human glycosylation disorders","volume":"38","author":"Freeze","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejmg.2022.104473_bib7","first-page":"11","article-title":"ALG13-CDG with infantile spasms in a male patient due to a de novo ALG13 gene mutation","volume":"40","author":"Galama","year":"2018","journal-title":"JIMD Rep"},{"issue":"10","key":"10.1016\/j.ejmg.2022.104473_bib8","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/ajmg.a.38377","article-title":"ALG13-CDG in a male with seizures, normal cognitive development, and normal transferrin isoelectric focusing","volume":"173","author":"Gadomski","year":"2017","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2022.104473_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41420-020-00319-6","article-title":"ALG13 participates in epileptogenesis via regulation of GABA A receptors in mouse models","volume":"6","author":"Huo","year":"2020","journal-title":"Cell Death Discov. Cell"},{"issue":"2","key":"10.1016\/j.ejmg.2022.104473_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/ijms19020619","article-title":"Stroke-like episodes and cerebellar syndrome in phosphomannomutase deficiency (PMM2-CDG): evidence for hypoglycosylation-driven channelopathy","volume":"19","author":"Izquierdo-Serra","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejmg.2022.104473_bib12","first-page":"271","article-title":"Gestational alloimmune liver disease","volume":"37","author":"Kasko","year":"2018","journal-title":"A Case Study"},{"issue":"3","key":"10.1016\/j.ejmg.2022.104473_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajmg.c.30143","article-title":"Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia)","volume":"145C","author":"Krasnewich","year":"2007","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"12","key":"10.1016\/j.ejmg.2022.104473_bib14","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41380-020-0753-1","article-title":"Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research","volume":"25","author":"Mealer","year":"2020","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104473_bib15","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1038\/s41598-020-70108-9","article-title":"The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation","volume":"10","author":"Mealer","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejmg.2022.104473_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tig.2018.03.002","article-title":"Perspectives on glycosylation and its congenital disorders","volume":"34","author":"Ng","year":"2018","journal-title":"Trends Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2022.104473_bib17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/jimd.12290","article-title":"Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: clinical description, biomarker status, biochemical analysis, and treatment suggestions","volume":"43","author":"Ng","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104473_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jimd.12126","article-title":"CDG and immune response: from bedside to bench and back","volume":"43","author":"Pascoal","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmg.2022.104473_bib19","first-page":"471","volume":"vol 37","author":"Pegg","year":"2020"},{"issue":"5","key":"10.1016\/j.ejmg.2022.104473_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/glycob\/cwu015","article-title":"The role of protein N-glycosylation in neural transmission","volume":"24","author":"Scott","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejmg.2022.104473_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1073\/pnas.92.3.841","article-title":"The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy","volume":"92","author":"Sims","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"19","key":"10.1016\/j.ejmg.2022.104473_bib22","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1093\/hmg\/dds123","article-title":"Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing","volume":"21","author":"Timal","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2022.104473_bib24","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/ajmg.a.38235","article-title":"Three families with mild PMM2-CDG and normal cognitive development","volume":"173","author":"Vals","year":"2017","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104473_bib25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000477616","article-title":"Antenatal treatment with intravenous immunoglobulin to prevent gestational alloimmune liver disease: comparative effectiveness of 14-week versus 18-week initiation","volume":"43","author":"Whitington","year":"2017","journal-title":"Fetal Diagn. Ther."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104473_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-018-9455-2","article-title":"Impact of pregnancy on inborn errors of metabolism","volume":"19","author":"Wilcox","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"Suppl. A","key":"10.1016\/j.ejmg.2022.104473_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/ejpn.2000.0428","article-title":"Lysosomal membrane proteins","volume":"5","author":"Winchester","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104473_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13023-020-01609-z","article-title":"D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial","volume":"16","author":"Witters","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.ejmg.2022.104473_bib29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2017.41","article-title":"Oral D-galactose supplementation in PGM1- CDG. Genetics in medicine","volume":"19","author":"Wong","year":"2017","journal-title":"Genet. Med."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:52:33Z","timestamp":1761709953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721222000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1769721222000544"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104473","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could distal variants in ALG13 lead to atypical clinical presentation?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104473"}}